UniProt ID | ARI3B_HUMAN | |
---|---|---|
UniProt AC | Q8IVW6 | |
Protein Name | AT-rich interactive domain-containing protein 3B | |
Gene Name | ARID3B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 561 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor which may be involved in neuroblastoma growth and malignant transformation. Favors nuclear targeting of ARID3A.. | |
Protein Sequence | MEPLQQQQQQQQQQQKQPHLAPLQMDAREKQGQQMREAQFLYAQKLVTQPTLLSATAGRPSGSTPLGPLARVPPTAAVAQVFERGNMNSEPEEEDGGLEDEDGDDEVAEVAEKETQAASKYFHVQKVARQDPRVAPMSNLLPAPGLPPHGQQAKEDHTKDASKASPSVSTAGQPNWNLDEQLKQNGGLAWSDDADGGRGREISRDFAKLYELDGDPERKEFLDDLFVFMQKRGTPINRIPIMAKQILDLYMLYKLVTEKGGLVEIINKKIWREITKGLNLPTSITSAAFTLRTQYMKYLYAYECEKKALSSPAELQAAIDGNRREGRRPSYSSSLFGYSPAAATAAAAAGAPALLSPPKIRFPILGLGSSSGTNTSSPRISPATTLRKGDGAPVTTVPVPNRLAVPVTLASQQAGTRTAALEQLRERLESGEPAEKKASRLSEEEQRLVQQAFQRNFFSMARQLPMKIRINGRAEDRAEASAAALNLTTSSIGSINMSVDIDGTTYAGVLFAQKPVVHLITGSAPQSLGSSASSSSSSHCSPSPTSSRGTPSAEPSTSWSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEPLQQQQ -------CCHHHHHH | 12.35 | 19413330 | |
61 | Phosphorylation | SATAGRPSGSTPLGP HHCCCCCCCCCCCCC | 43.97 | 28555341 | |
75 | Phosphorylation | PLARVPPTAAVAQVF CCCCCCCCHHHHHHH | 22.60 | - | |
89 | Phosphorylation | FERGNMNSEPEEEDG HHCCCCCCCCCCCCC | 43.70 | 22617229 | |
89 (in isoform 4) | Phosphorylation | - | 43.70 | - | |
120 | Acetylation | KETQAASKYFHVQKV HHHHHHHHHHHHHHH | 47.40 | 30587025 | |
121 | Phosphorylation | ETQAASKYFHVQKVA HHHHHHHHHHHHHHH | 9.09 | 27642862 | |
162 | Phosphorylation | EDHTKDASKASPSVS HHHCCCHHHCCCCCC | 38.60 | 28450419 | |
165 | Phosphorylation | TKDASKASPSVSTAG CCCHHHCCCCCCCCC | 22.80 | 25159151 | |
165 | O-linked_Glycosylation | TKDASKASPSVSTAG CCCHHHCCCCCCCCC | 22.80 | 23301498 | |
165 (in isoform 4) | Phosphorylation | - | 22.80 | 27251275 | |
167 | Phosphorylation | DASKASPSVSTAGQP CHHHCCCCCCCCCCC | 26.63 | 30108239 | |
169 | Phosphorylation | SKASPSVSTAGQPNW HHCCCCCCCCCCCCC | 19.51 | 30108239 | |
170 | Phosphorylation | KASPSVSTAGQPNWN HCCCCCCCCCCCCCC | 32.43 | 28450419 | |
208 | Ubiquitination | EISRDFAKLYELDGD EECHHHHHHHCCCCC | 52.15 | 29967540 | |
210 | Phosphorylation | SRDFAKLYELDGDPE CHHHHHHHCCCCCHH | 17.46 | 27642862 | |
234 | Phosphorylation | VFMQKRGTPINRIPI HHHHHCCCCCCHHHH | 25.65 | 26670566 | |
286 | Phosphorylation | NLPTSITSAAFTLRT CCCCHHHHHHHHHHH | 18.87 | - | |
290 | Phosphorylation | SITSAAFTLRTQYMK HHHHHHHHHHHHHHH | 15.59 | 24719451 | |
310 | Phosphorylation | ECEKKALSSPAELQA HHHHHHCCCHHHHHH | 38.85 | 30108239 | |
311 | Phosphorylation | CEKKALSSPAELQAA HHHHHCCCHHHHHHH | 29.04 | 21815630 | |
330 | Phosphorylation | RREGRRPSYSSSLFG CCCCCCCCCCCCHHC | 35.52 | 28450419 | |
331 | Phosphorylation | REGRRPSYSSSLFGY CCCCCCCCCCCHHCC | 18.43 | 28450419 | |
331 (in isoform 4) | Phosphorylation | - | 18.43 | 24719451 | |
332 | Phosphorylation | EGRRPSYSSSLFGYS CCCCCCCCCCHHCCC | 20.14 | 28450419 | |
332 (in isoform 4) | Phosphorylation | - | 20.14 | 27251275 | |
333 | Phosphorylation | GRRPSYSSSLFGYSP CCCCCCCCCHHCCCH | 23.87 | 28450419 | |
334 | Phosphorylation | RRPSYSSSLFGYSPA CCCCCCCCHHCCCHH | 23.06 | 30576142 | |
338 | Phosphorylation | YSSSLFGYSPAAATA CCCCHHCCCHHHHHH | 12.26 | 30576142 | |
339 | Phosphorylation | SSSLFGYSPAAATAA CCCHHCCCHHHHHHH | 14.40 | 28450419 | |
344 | Phosphorylation | GYSPAAATAAAAAGA CCCHHHHHHHHHCCC | 16.47 | 28450419 | |
356 | Phosphorylation | AGAPALLSPPKIRFP CCCCHHCCCCCCCCC | 39.75 | 30108239 | |
361 | Asymmetric dimethylarginine | LLSPPKIRFPILGLG HCCCCCCCCCEECCC | 37.10 | - | |
361 | Methylation | LLSPPKIRFPILGLG HCCCCCCCCCEECCC | 37.10 | - | |
371 | Phosphorylation | ILGLGSSSGTNTSSP EECCCCCCCCCCCCC | 51.86 | 29978859 | |
373 | Phosphorylation | GLGSSSGTNTSSPRI CCCCCCCCCCCCCCC | 36.95 | 29978859 | |
375 | Phosphorylation | GSSSGTNTSSPRISP CCCCCCCCCCCCCCC | 30.35 | 29978859 | |
376 | Phosphorylation | SSSGTNTSSPRISPA CCCCCCCCCCCCCCC | 40.18 | 29978859 | |
377 | Phosphorylation | SSGTNTSSPRISPAT CCCCCCCCCCCCCCC | 19.03 | 18669648 | |
377 (in isoform 4) | Phosphorylation | - | 19.03 | - | |
381 | Phosphorylation | NTSSPRISPATTLRK CCCCCCCCCCCCCCC | 15.12 | 30108239 | |
384 (in isoform 4) | Phosphorylation | - | 29.73 | - | |
384 | Phosphorylation | SPRISPATTLRKGDG CCCCCCCCCCCCCCC | 29.73 | 18669648 | |
395 | Phosphorylation | KGDGAPVTTVPVPNR CCCCCCCEEEECCCC | 22.48 | 24129246 | |
396 | Phosphorylation | GDGAPVTTVPVPNRL CCCCCCEEEECCCCE | 24.05 | 24129246 | |
402 | Methylation | TTVPVPNRLAVPVTL EEEECCCCEEEECEE | 20.25 | - | |
408 | O-linked_Glycosylation | NRLAVPVTLASQQAG CCEEEECEEECCCCC | 15.55 | 23301498 | |
411 | O-linked_Glycosylation | AVPVTLASQQAGTRT EEECEEECCCCCCHH | 26.41 | 23301498 | |
416 | O-linked_Glycosylation | LASQQAGTRTAALEQ EECCCCCCHHHHHHH | 28.06 | 23301498 | |
439 | Phosphorylation | EPAEKKASRLSEEEQ CCHHHHHHHCCHHHH | 42.51 | - | |
442 | Phosphorylation | EKKASRLSEEEQRLV HHHHHHCCHHHHHHH | 41.68 | 24905233 | |
521 | Phosphorylation | KPVVHLITGSAPQSL CCEEEEEECCCCCHH | 31.29 | 29449344 | |
523 | Phosphorylation | VVHLITGSAPQSLGS EEEEEECCCCCHHCC | 28.29 | 29449344 | |
527 | Phosphorylation | ITGSAPQSLGSSASS EECCCCCHHCCCCCC | 33.37 | 29449344 | |
530 | Phosphorylation | SAPQSLGSSASSSSS CCCCHHCCCCCCCCC | 28.20 | 29449344 | |
531 | Phosphorylation | APQSLGSSASSSSSS CCCHHCCCCCCCCCC | 30.30 | 29449344 | |
533 | Phosphorylation | QSLGSSASSSSSSHC CHHCCCCCCCCCCCC | 32.47 | 29449344 | |
534 | Phosphorylation | SLGSSASSSSSSHCS HHCCCCCCCCCCCCC | 33.68 | 29449344 | |
535 | Phosphorylation | LGSSASSSSSSHCSP HCCCCCCCCCCCCCC | 31.57 | 29449344 | |
536 | Phosphorylation | GSSASSSSSSHCSPS CCCCCCCCCCCCCCC | 37.50 | 29449344 | |
537 | Phosphorylation | SSASSSSSSHCSPSP CCCCCCCCCCCCCCC | 26.50 | 29449344 | |
538 | Phosphorylation | SASSSSSSHCSPSPT CCCCCCCCCCCCCCC | 30.38 | 29449344 | |
541 | Phosphorylation | SSSSSHCSPSPTSSR CCCCCCCCCCCCCCC | 24.00 | 29449344 | |
543 | Phosphorylation | SSSHCSPSPTSSRGT CCCCCCCCCCCCCCC | 25.23 | 29449344 | |
545 | Phosphorylation | SHCSPSPTSSRGTPS CCCCCCCCCCCCCCC | 43.61 | 29449344 | |
546 | Phosphorylation | HCSPSPTSSRGTPSA CCCCCCCCCCCCCCC | 22.79 | 29449344 | |
547 | Phosphorylation | CSPSPTSSRGTPSAE CCCCCCCCCCCCCCC | 36.89 | 29449344 | |
556 | Phosphorylation | GTPSAEPSTSWSL-- CCCCCCCCCCCCC-- | 26.95 | 21406692 | |
557 | Phosphorylation | TPSAEPSTSWSL--- CCCCCCCCCCCC--- | 44.95 | 21406692 | |
558 | Phosphorylation | PSAEPSTSWSL---- CCCCCCCCCCC---- | 21.00 | 21406692 | |
558 | O-linked_Glycosylation | PSAEPSTSWSL---- CCCCCCCCCCC---- | 21.00 | 23301498 | |
560 | Phosphorylation | AEPSTSWSL------ CCCCCCCCC------ | 24.78 | 30108239 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ARI3B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARI3B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARI3B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-165, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-165, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89, AND MASSSPECTROMETRY. |